| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Pulmonary Center, Department of Medicine, Boston University Medical School, Boston, MA, USA
2 Department of Biochemistry, Boston University Medical School, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: wcardoso{at}lung.bumc.bu.edu.
Fibroblast growth factor (Fgf) 10 is a critical regulator of bud formation during lung morphogenesis. Fgf10 is expressed in distal lung mesenchyme at sites of prospective budding from the earliest developmental stages and signals through its epithelial receptor Fgfr2b. Experiments in intact lung organ cultures demonstrate that Fgf10 is a chemotactic factor for distal but not for proximal epithelium. This differential response suggests the involvement of an additional mechanism regulating Fgf10-Fgfr2b interactions, since Fgfr2b is uniformly expressed throughout the respiratory tract. Here we use an immunohistochemistry-based binding assay to show that O-sulfated heparan sulfates (HS) are critical for Fgf10 binding to the distal epithelium. We show that altering endogenous gradients of HS sulfation with sodium chlorate or over-O-sulfated synthetic heparin in lung organ cultures dramatically decreases Fgf10 binding. Moreover we show that under these conditions epithelial binding is not improved by providing exogenous FGF10. Our data suggest that, not only ligand availability, but also the presence of specific patterns of HS modification in the distal lung epithelium are critical determinants of Fgf10 binding to the epithelium and signaling.
This article has been cited by other articles:
|
|
 |
|
  M. M. Fuster, L. Wang, J. Castagnola, L. Sikora, K. Reddi, P. H.A. Lee, K. A. Radek, M. Schuksz, J. R. Bishop, R. L. Gallo, et al. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis J. Cell Biol., May 7, 2007; 177(3): 539 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Benjamin, R. J. Smith, B. A. Halloran, T. J. Day, D. R. Kelly, and L. S. Prince FGF-10 is decreased in bronchopulmonary dysplasia and suppressed by Toll-like receptor activation Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L550 - L558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. V. Cardoso and J. Lu Regulation of early lung morphogenesis: questions, facts and controversies Development, May 1, 2006; 133(9): 1611 - 1624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Steinberg, C. Myers, V. M. Heim, C. A. Lathrop, I. T. Rebustini, J. S. Stewart, M. Larsen, and M. P. Hoffman FGFR2b signaling regulates ex vivo submandibular gland epithelial cell proliferation and branching morphogenesis Development, March 15, 2005; 132(6): 1223 - 1234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Hyatt, X. Shangguan, and J. M. Shannon FGF-10 induces SP-C and Bmp4 and regulates proximal-distal patterning in embryonic tracheal epithelium Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1116 - L1126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Shannon, K. McCormick-Shannon, M. S. Burhans, X. Shangguan, K. Srivastava, and B. A. Hyatt Chondroitin sulfate proteoglycans are required for lung growth and morphogenesis in vitro Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1323 - L1336. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
